It is assumed that a chronic disease progresses from a pre-clinical state to a clinical state. If an individual, having pre-clinical disease, participates in an early detection programme, the disease may be detected in the pre-clinical state. The potential benefit of a screening programme is related to the lead time gained by early diagnosis. A stochastic model is developed for early detection programmes which leads to an estimate of the mean lead time as a function of observable variables. An investigation is also made of a non-progressive disease model in which individuals in a pre-clinical state may not necessarily advance to the clinical state.
No takes yet. Share an insight, caveat, or question.
Zelen et al. (1969) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: